Lisinopril And Hydrochlorothiazide Tablet
Product Images NDC 71335-0479

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Lisinopril And Hydrochlorothiazide (NDC 71335-0479). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

3a53f18e Af9b 4932 8300 B3521e87528d 01

Chemical structure of Lisinopril dihydrate, an active ingredient in Lisinopril and Hydrochlorothiazide tablets. The diagram shows the molecular formula with atoms and bonds, including the dihydrate form.*

FDA Label Image

3a53f18e Af9b 4932 8300 B3521e87528d 02

Chemical structure diagram of Hydrochlorothiazide, one of the active ingredients in Lisinopril and Hydrochlorothiazide tablets. The structure includes chlorine, sulfonamide, and other molecular groups typical of Hydrochlorothiazide.*

FDA Label Image

Label Image (Lbl713350479)

Label for Lisinopril and Hydrochlorothiazide 10 mg/12.5 mg oral tablet by Bryant Ranch Prepack. The label includes dosage strength, a barcode, storage instructions (20-25°C), a note to keep out of reach of children, and comparison to Zestoretic 10/12.5 mg tablet by Lupin Limited. The NDC 71335-0479 is highlighted.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.